7 results
Table 4. Recommended Initial Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (Non-Ventilator-Associated Pneumonia) #Management #InfectiousDiseases #Empiric #Antibiotics
Table 4. ... Initial Empiric Antibiotic ... Therapy for Hospital-Acquired ... Pneumonia (Non-Ventilator-Associated ... Pneumonia) #Management
Antibiotics for Atypical Bacteria 
 - Macrolides   (Azithromycin) 
 - Tetracyclines   (Doxycycline)
Antibiotics for ... Strong Medicine #Antibiotics ... Atypical #Bacteria #Pharmacology ... #Table #Susceptibility ... #Coverage #Management
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
with Community-Acquired ... Pneumonia (CAP) ... #Pneumonia #Antibiotics ... Treatment #Regimen #Management ... #Guidelines #pharmacology
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
• Community acquired ... pneumonia and CRB65 ... pneumonia and CRB65 ... #management #durations ... outpatient #treatment #pharmacology
Antibiotics for severe community-onset pneumonia 

Atypical coverage always 

- Usually azithromycin 500 mg daily 

- Doxycycline
community-onset pneumonia ... piperacillin-tazobactam Septic Shock ... #Community #Acquired ... #Pneumonia #CAP ... #Management
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagylâ„¢) 
 - Carbapenems 
 - β lactam +
Antibiotics for ... Strong Medicine #Antibiotics ... Anaerobic #Bacteria #Pharmacology ... #Table #Susceptibility ... #Coverage #Management
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... B for initial management ... Severe cryptococcal pneumonia ... of primary and acquired ... #Pharmacology #Antibiotics